DE50001217D1 - Stabile xylometazolin- und oxymetazolinlösung - Google Patents

Stabile xylometazolin- und oxymetazolinlösung

Info

Publication number
DE50001217D1
DE50001217D1 DE50001217T DE50001217T DE50001217D1 DE 50001217 D1 DE50001217 D1 DE 50001217D1 DE 50001217 T DE50001217 T DE 50001217T DE 50001217 T DE50001217 T DE 50001217T DE 50001217 D1 DE50001217 D1 DE 50001217D1
Authority
DE
Germany
Prior art keywords
oxymetazoline solution
xylometazoline
stable
stable xylometazoline
oxymetazoline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE50001217T
Other languages
German (de)
English (en)
Inventor
Ulrich Maerz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23322017&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE50001217(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Application granted granted Critical
Publication of DE50001217D1 publication Critical patent/DE50001217D1/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/4174Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/38Silver; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Cosmetics (AREA)
DE50001217T 1999-06-22 2000-06-17 Stabile xylometazolin- und oxymetazolinlösung Revoked DE50001217D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33778999A 1999-06-22 1999-06-22
PCT/EP2000/005583 WO2000078297A2 (de) 1999-06-22 2000-06-17 Stabile xylometazolin- und oxymetazolinlösung

Publications (1)

Publication Number Publication Date
DE50001217D1 true DE50001217D1 (de) 2003-03-13

Family

ID=23322017

Family Applications (1)

Application Number Title Priority Date Filing Date
DE50001217T Revoked DE50001217D1 (de) 1999-06-22 2000-06-17 Stabile xylometazolin- und oxymetazolinlösung

Country Status (22)

Country Link
US (2) US20040191177A1 (enExample)
EP (1) EP1194145B1 (enExample)
JP (1) JP2003502361A (enExample)
KR (1) KR20020012001A (enExample)
CN (1) CN1164271C (enExample)
AT (1) ATE232099T1 (enExample)
AU (1) AU765736B2 (enExample)
BR (1) BR0011950A (enExample)
CA (1) CA2376121C (enExample)
CZ (1) CZ295595B6 (enExample)
DE (1) DE50001217D1 (enExample)
EA (1) EA003329B1 (enExample)
ES (1) ES2188563T3 (enExample)
HK (1) HK1045945B (enExample)
HU (1) HUP0201700A3 (enExample)
IL (1) IL147023A0 (enExample)
MX (1) MXPA01012912A (enExample)
PL (1) PL197542B1 (enExample)
PT (1) PT1194145E (enExample)
TR (1) TR200103694T2 (enExample)
WO (1) WO2000078297A2 (enExample)
ZA (1) ZA200110386B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1446119T3 (da) 2001-09-18 2006-07-10 Nycomed Danmark Aps Præparater omfattende Ipratropium og xylometazolin til behandling af almindelig forkölelse
WO2004000272A1 (en) * 2002-06-20 2003-12-31 Novartis Consumer Health S.A. Nasal compositions comprising a mucopolysaccharide and propylene glycol
AU2003272517A1 (en) * 2002-09-13 2004-04-30 Zicam, Llc. Compositions to reduce congestion and methods for application thereof to the nasal membrane
DE10337186A1 (de) * 2003-08-13 2005-03-17 Merck Patent Gmbh Wässrige Wirkstoff-Lösung
US8685439B2 (en) * 2006-04-26 2014-04-01 Aciex Therapeutics, Inc. Method for the treatment and prevention of eyelid swelling
US20090136598A1 (en) * 2006-04-26 2009-05-28 Aciex, Inc. Compositions for the Treatment and Prevention of Eyelid Swelling
CN101912363A (zh) * 2010-07-29 2010-12-15 蔡海德 溶解超滤-喷雾干燥-分子分散包衣-水化制粒-冷冻干燥生产脂质体组合药物
PL3236933T3 (pl) 2014-12-24 2019-05-31 Jadran Galenski Laboratorij D D Kompozycja do podawania donosowego zawierająca wodę morską jako zaróbkę poprawiającą trwałość
WO2023046590A1 (en) 2021-09-22 2023-03-30 Jadran - Galenski Laboratorij D.D. An improved pharmaceutical composition for nasal use, preparation, and use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4603131A (en) * 1982-04-26 1986-07-29 Bernstein Joel E Method and composition for treating and preventing irritation of the mucous membranes of the nose
US4970240A (en) * 1989-10-18 1990-11-13 Schering Corporation Fruity flavored nasal decongestant composition
US5114979A (en) * 1989-10-18 1992-05-19 Schering Corporation Fruity flavored nasal decongestant composition
US5540930A (en) * 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
DE19549421C2 (de) * 1995-11-10 1999-11-18 Klosterfrau Mcm Vetrieb Gmbh Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden
EP0861128B1 (de) * 1995-11-17 2003-02-19 Ursatec Verpackung Gmbh Vor kontamination schützende abgabevorrichtung für fluide
DE19542959C1 (de) * 1995-11-17 1996-10-24 Ursatec Verpackung Gmbh Vor Kontamination schützende Abgabevorrichtung für Fluide
NZ505919A (en) * 1998-01-30 2002-10-25 Novartis Consumer Health S Nasal solutions

Also Published As

Publication number Publication date
HK1045945A1 (en) 2002-12-20
ATE232099T1 (de) 2003-02-15
PL352354A1 (en) 2003-08-11
US20080011293A1 (en) 2008-01-17
HK1045945B (zh) 2005-01-28
KR20020012001A (ko) 2002-02-09
TR200103694T2 (tr) 2002-04-22
PL197542B1 (pl) 2008-04-30
CA2376121A1 (en) 2000-12-28
AU6150600A (en) 2001-01-09
MXPA01012912A (es) 2002-09-18
CN1164271C (zh) 2004-09-01
WO2000078297A3 (de) 2001-03-01
HUP0201700A2 (hu) 2002-12-28
IL147023A0 (en) 2002-08-14
HUP0201700A3 (en) 2003-02-28
BR0011950A (pt) 2002-03-12
ZA200110386B (en) 2003-04-22
EA003329B1 (ru) 2003-04-24
PT1194145E (pt) 2003-06-30
CN1361689A (zh) 2002-07-31
EP1194145B1 (de) 2003-02-05
EP1194145A2 (de) 2002-04-10
AU765736B2 (en) 2003-09-25
CZ20014568A3 (cs) 2002-03-13
JP2003502361A (ja) 2003-01-21
EA200200042A1 (ru) 2002-06-27
WO2000078297A2 (de) 2000-12-28
CZ295595B6 (cs) 2005-08-17
ES2188563T3 (es) 2003-07-01
CA2376121C (en) 2008-06-10
US20040191177A1 (en) 2004-09-30

Similar Documents

Publication Publication Date Title
DE60216951D1 (de) Hydrolysestabile selbstätzender, selbstgrundierender klebstoff
AR028563A1 (es) Compuestos heterociclicos que contienen n
DE50105476D1 (de) Stent
ATE319666T1 (de) Gipszusammensetzung mit verbesserter deformationsstabilität
DE60111242D1 (de) Biegsames implantat
EP1417988A4 (en) RESPIRATORY EQUIPMENT
BR0209242A (pt) Aminopolidiorganossiloxanos amido-funcionais
DE69932460D1 (de) Sprachkodierer/dekodierer
ATE297736T1 (de) Hochkonzentrierte stabile meloxicam-lösungen
FI20001577A0 (fi) Puheenkoodaus
DE50100948D1 (de) Herstellung von Organosilanen
DE50001217D1 (de) Stabile xylometazolin- und oxymetazolinlösung
ATE450652T1 (de) Wässrige zusammensetzung
ITGE20000040A0 (it) Machera subacquea con compensazione.
DE60223732D1 (de) Füllminenstift
DE69912860D1 (de) Mehrfachinstanzimplementierung von sprachkodierer-dekodierern
DE50213427D1 (de) Durchführungsanordnung
ATE295746T1 (de) Radioaktiv beschichtete stents
NO20024877L (no) Direkte kodensasjon
ES1050762Y (es) Juguete que contiene golosinas
UA5432S (uk) Пенал
UA4164S (uk) Манометр
FI5685U1 (fi) Kirjekuori
DE60238157D1 (de) Flexibler Stent
SE0102267D0 (sv) Remote updating

Legal Events

Date Code Title Description
8363 Opposition against the patent
8331 Complete revocation